Aditum Bio, the biotech company creation firm from former Novartis leaders Joe Jimenez and Mark Fishman, has returned to China for another deal. This time,

Prior to last month’s series of mass layoffs in Maryland, Catalent was issued two Form 483s for its gene therapy facilities in the state, which

We’re a bit less than a month out from the JP Morgan meeting, where we’ll host our own event on Monday and Tuesday that week

This is our final Peer Review in 2025. Thank you for reading the latest comings and goings for another year. Enjoy the holidays, and we’ll

A US congressional commission is escalating its warning that the US could soon be eclipsed by China in biotech, after lawmakers took up some of